Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammad Wasif Saif

Showing results (21-30 of 473) with videos related to

Pageof 48
Sort By:
JOP : Journal of the Pancreas|May 11, 2006
Primary pancreatic lymphomasMuhammad Wasif Saif
Expert Opinion on Biological Therapy|September 21, 2013
Antiangiogenesis therapy in second line metastatic colorectal cancer: similar but differentMuhammad Wasif Saif
Anticancer Research|June 11, 2013
Is there a benefit from addiction to anti-VEGF therapy in patients with colorectal cancer?Muhammad Wasif Saif
Cancer Management and Research|June 29, 2013
Anti-VEGF agents in metastatic colorectal cancer (mCRC): are they all alike?Muhammad Wasif Saif
JOP : Journal of the Pancreas|November 13, 2013
U.S. Food and Drug Administration approves paclitaxel protein-bound particles (Abraxane®) in combination with gemcitabine as first-line treatment of patients with metastatic pancreatic cancerMuhammad Wasif Saif
JOP : Journal of the Pancreas|March 9, 2010
Pulmonary toxicity associated with gemcitabineMuhammad Wasif Saif
The Journal of Applied Research|March 12, 2010
Malignant Ascites Associated with Carcinoma of the ProstateMuhammad Wasif Saif
JOP : Journal of the Pancreas|July 24, 2008
New developments in the treatment of pancreatic cancer. Highlights from the "44th ASCO Annual Meeting". Chicago, IL, USA. May 30 - June 3, 2008Muhammad Wasif Saif
JOP : Journal of the Pancreas|July 24, 2008
Translational research in pancreatic cancer. Highlights from the "44th ASCO Annual Meeting". Chicago, IL, USA. May 30 - June 3, 2008Muhammad Wasif Saif
JOP : Journal of the Pancreas|September 9, 2020
New Developments in the Treatment of Pancreatic Cancer: Highlights from the 44th ASCO Annual Virtual Meeting, May 29-31, 2020Muhammad Wasif Saif
Pageof 48

Showing results (21-30 of 473) with videos related to

Sort By:
Pageof 48
JOP : Journal of the Pancreas|May 11, 2006
Primary pancreatic lymphomasMuhammad Wasif Saif
Expert Opinion on Biological Therapy|September 21, 2013
Antiangiogenesis therapy in second line metastatic colorectal cancer: similar but differentMuhammad Wasif Saif
Anticancer Research|June 11, 2013
Is there a benefit from addiction to anti-VEGF therapy in patients with colorectal cancer?Muhammad Wasif Saif
Cancer Management and Research|June 29, 2013
Anti-VEGF agents in metastatic colorectal cancer (mCRC): are they all alike?Muhammad Wasif Saif
JOP : Journal of the Pancreas|November 13, 2013
U.S. Food and Drug Administration approves paclitaxel protein-bound particles (Abraxane®) in combination with gemcitabine as first-line treatment of patients with metastatic pancreatic cancerMuhammad Wasif Saif
JOP : Journal of the Pancreas|March 9, 2010
Pulmonary toxicity associated with gemcitabineMuhammad Wasif Saif
The Journal of Applied Research|March 12, 2010
Malignant Ascites Associated with Carcinoma of the ProstateMuhammad Wasif Saif
JOP : Journal of the Pancreas|July 24, 2008
New developments in the treatment of pancreatic cancer. Highlights from the "44th ASCO Annual Meeting". Chicago, IL, USA. May 30 - June 3, 2008Muhammad Wasif Saif
JOP : Journal of the Pancreas|July 24, 2008
Translational research in pancreatic cancer. Highlights from the "44th ASCO Annual Meeting". Chicago, IL, USA. May 30 - June 3, 2008Muhammad Wasif Saif
JOP : Journal of the Pancreas|September 9, 2020
New Developments in the Treatment of Pancreatic Cancer: Highlights from the 44th ASCO Annual Virtual Meeting, May 29-31, 2020Muhammad Wasif Saif
Pageof 48